Trial intelligence / Profile preview

Colchicine in Acutely Decompensated Heart Failure

NCT06286423Phase 4Recruiting

Sponsor
University of Virginia
Start
Jun 2024
Primary completion
Jun 2026
Modality
Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of colchicine in Acute Decompensated Heart Failure (ADHF), sponsored by University of Virginia. Started Jun 2024; status: recruiting.

02

Drugs

colchicine
03

Conditions

Acute Decompensated Heart Failure (ADHF)

Beyond the preview

Go deeper on NCT06286423.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06286423.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call